Immunology
-
Long-lasting humoral immunity in Covid-19 infected patients at a University Hospital Clinic in Östergötland County Council during 2020-2021
This article has 11 authors:Reviewed by ScreenIT
-
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
This article has 20 authors:Reviewed by ScreenIT
-
Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals
This article has 15 authors:Reviewed by ScreenIT
-
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat RBD of SARS-CoV-2 spike protein protects mice against COVID-19
This article has 20 authors:Reviewed by ScreenIT
-
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates
This article has 54 authors:Reviewed by ScreenIT
-
Functional immune mapping with deep-learning enabled phenomics applied to immunomodulatory and COVID-19 drug discovery
This article has 32 authors:Reviewed by ScreenIT
-
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
This article has 18 authors:Reviewed by ScreenIT
-
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
This article has 35 authors:Reviewed by ScreenIT
-
Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants
This article has 66 authors:Reviewed by ScreenIT
-
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
This article has 24 authors:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases